Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

NCT00486356 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Nebraska

Collaborators